Natera Inc

$36.87 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Natera Inc

Natera, Inc. is a diagnostics company. The Company is focused on the development and commercialization of molecular testing services, applying its technology in the fields of women’s health, oncology and organ health. The Company’s cell-free DNA (cfDNA) technology combines its molecular assays, which reliably measure many informative regions across the genome from samples as small as a single cell. The Company's product offerings include Panorama Non-Invasive Prenatal Test (NIPT), Vistara, Horizon Carrier Screening (HCS), Spectrum Pre-implantation Genetics (Spectrum), Anora Miscarriage Test (Anora), Non-Invasive Paternity Testing (PAT) and Prospera. The Company also offers Constellation, a cloud-based software platform that enables laboratory customers to gain access through the cloud to the Company’s algorithms and bioinformatics in order to validate and launch tests based on the Company’s technology.

Stock Analysis

last close $37.72
1-mo return -8.4%
3-mo return -6.3%
avg daily vol. 1.25M
52-week high 129.09
52-week low 26.1
market cap. $4.0B
forward pe -
annual div. -
roe -119.5%
ltg forecast -
dividend yield -
annual rev. $667M
inst own. 99.1%

Subscribe now for daily local and international financial news